Skip to main content
Isodiol International Inc. logo

Isodiol International Inc. — Investor Relations & Filings

Ticker · ISOLF ISIN · CA46500L2003 LEI · 5299007G3O2KRPA6SD57 CSE Manufacturing
Open in API
Filings indexed 12 across all filing types
Latest filing 2021-04-05 Legal Proceedings Report
Country CA Canada
Listing CSE ISOLF

About Isodiol International Inc.

https://isodiol.com

Isodiol International Inc. is engaged in the development, manufacturing, and global distribution of hemp-based consumer packaged goods and phytoceutical solutions. The company specializes in extracting and processing cannabidiol (CBD) to the highest available purity, leveraging industrial-scale hemp cultivation. Isodiol is positioned as a market leader in pharmaceutical-grade phytochemical compounds, focusing on the nutritional health benefits of hemp. Its product portfolio includes essential oils, oral sprays, and various hemp oil formulations, distributed through its product development, sales, and marketing operations.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Legal Proceedings Report Classification · 95% confidence The document is a press release titled 'ISODIOL INTERNATIONAL INC. FILES NOTICE OF CIVIL CLAIM AGAINST BRAIN BIOCEUTICAL CORP FOR BREACH OF CONTRACT & UPDATE ON STOCK TRADING HALT'. It details a legal claim filed by Isodiol International Inc. against another company for breach of contract, including specifics of the claim, payment history, and requested relief. It also provides an update on the company's stock trading halt due to delays in financial reporting caused by the COVID-19 pandemic. The content focuses on legal proceedings and corporate updates related to litigation and financial reporting delays, rather than financial results, management changes, or regulatory filings. There is no indication that this is a full audit report or financial statement, nor is it a regulatory filing or certification. The primary subject is the legal claim and related corporate update, which fits the category of Legal Proceedings Report (LTR).
2021-04-05 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a corporate update press release from Isodiol International Inc. It discusses recent restructuring actions, leadership changes, audit challenges, and strategic plans for future growth. The text includes no detailed financial statements, no quarterly or annual financial results, no audit report details, and no regulatory filings or certifications. It is a narrative update aimed at investors and the public, describing corporate governance improvements, trade halt, and future plans. The document is not a formal financial report, earnings release, or regulatory filing but rather a corporate update announcement. Therefore, the most appropriate classification is a Capital/Financing Update (CAP) because it includes information about restructuring, trade halt, and plans to secure outside investment, which are financing-related corporate updates.
2021-04-05 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a default announcement pursuant to National Policy 12-203 regarding a management cease trade order due to the company's failure to file its audited annual financial statements and management's discussion and analysis by the prescribed deadline. It discusses regulatory relief due to COVID-19, the company's efforts to file the required annual filings, and the imposition of a management cease trade order (MCTO). The document does not contain the actual annual report or financial statements but is an announcement about the delay and regulatory consequences. It is a regulatory announcement related to compliance and disclosure defaults rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS). The document length is 4705 characters, which is relatively short and consistent with an announcement rather than a full report.
2020-09-16 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release from Isodiol International Inc. providing an update on the delay in filing its annual and interim financial statements. It references the annual financial statements for the year ended March 31, 2020, and interim financial statements for the three months ended June 30, 2020, but does not contain the actual financial statements or detailed financial data. Instead, it discusses reliance on regulatory relief for late filing and the expected future filing dates. The document is short (4513 characters) and serves as an announcement about the delay and expected filing, not the filings themselves. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about filing delays rather than the actual Annual Report (10-K) or Interim Report (IR).
2020-09-01 English
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and details a material change involving the issuance of common shares in payment of convertible debentures. It includes a news release announcing the material change and references securities laws and exemptions. The content focuses on a specific financing event (conversion of debentures to shares), which is a capital structure update. The document is not a full financial report, audit, or earnings release, but rather an official announcement of a material change related to financing. Therefore, it fits best under 'Capital/Financing Update (CAP)'. The document length (5540 characters) supports it being a full announcement rather than a brief notice or a report publication announcement.
2020-08-07 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the issuance of common shares due to the conversion of convertible debentures. It discusses the conversion of debt into equity, the outstanding principal amount, and the expected impact on the company's balance sheet and debt servicing costs. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is focused on a capital structure change related to financing activities. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is under 5,000 characters and it is not an announcement of a report publication but a substantive update on financing activity.
2020-08-04 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.